Home Sequential Compression Devices Market is expected to reach US$ 1,572.81 million by Cardinal Health Inc; Biocompression Systems; DJO Global, Inc.; DSMAREF CO.LTD; Precision Medical Products; AIROS Medical; Breg Inc.; Mego Afek ltd.; Arjo Medical Devic

According to The Insight Partners market research study of “Home sequential compression devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by , Device Type, Type, Application, and Geography”, the global home sequential compression devices market is expected to reach US$ 1,572.81 million by 2028 from US$ 992.49 million in 2021; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the global home sequential compression devices market and the factors driving market along with those that act as hindrances. The growth of the market is determined due to some of the key driving factors, rising number of orthopedic and spinal surgeries; growing number of patients suffering from DVT. However, lack of favorable reimbursement and transmission of post-operative infection associated with compression devices are likely to restrict market growth during the forecast period. Further, the availability of well-developed healthcare infrastructure and prompt government support are a few of the prominent factors propelling the market growth in North America.

Get a Sample Copy of the Report@ https://www.theinsightpartners.com/sample/TIPRE00019265/?openpr-10225

Based on by device type, the home sequential compression devices market is segmented into alternate sequential compression device (ASCD), simultaneous sequential compression device (SSCD). The simultaneous sequential compression device (SSCD) segment held the largest share of the market in 2021, and same segment is anticipated to register the highest CAGR in the market during the forecast period. Factors such as a factor such as rise prevalence of lymphatic and venous disorders and increasing awareness about the advance treatment involve use of sequential compression and other devices are driving the market growth. However, availability of alternate therapies hampers the growth of the market.

Due to growing demand for COVID related medical devices many companies have been prioritizing sales in their respective segments. For instance, in response to the coronavirus pandemic leading market players in compression therapy devices have been collaborating with suppliers to understand and manage the impact of the pandemic on product supply. For instance, Cardinal health has been partnering with trade groups including Health Industry Distributors Association (HIDA), Healthcare Distribution Alliance (HDA), National Community Pharmacists Association (NCPA), National Association of Chain Drug Stores (NACDS), Healthcare Ready, and AdvaMed to respond to industry wide challenges. Such a strategic initiatives will boost the home care devices market. Moreover, remote patient monitoring (RPM) in COVID-19 crisis offers tools for disease monitoring and patient-provider communications that reduce infection risks for patients, communities, and providers. These are especially safe and useful method of care as healthcare system works to combat COVID-19. Thus, owing to the above–mentioned factors, the pandemic has shown a positive impact on the home medical devices market, which will support the home sequential compression devices market.

Cardinal Health Inc; Biocompression Systems; DJO Global, Inc.; DSMAREF CO.LTD; Precision Medical Products; AIROS Medical; Breg Inc.; Mego Afek ltd.; Arjo Medical Devices; and Tactile Medical, Inc are among the leading companies operating in the home sequential compression devices market.

Market Insights

Prevalence of Lymphatic and Venous Disorders

Sequential compression devices (SCDs) are used as a part of venous thromboembolism (VTE). As per the Center for Disease Control and Prevention (CDC), blood clotting in a deep vein results in the VTE, which is primarily a condition of blood vessels. These clots generally develop in lower leg, thigh, or pelvis, and injury to veins, slow blood flow, increased estrogen levels, heart diseases, and obesity are among the main causes of the clot formation. As per a study published by StatPearls Publishing LLC in August 2020, more than 200,000 people in the US are reported to develop venous thrombosis annually. Moreover, as per the Thrombosis UK, 1 in 1000 people suffer from venous thrombosis every year. Venous disorders are caused due to factors such as pregnancy, obesity, varicose vein, and venous insufficiency. Venous insufficiency is observed in pregnancy mainly due to an enlarged gravid uterus, resulting in hypertension in the lower extremity veins and increased hormone secretion, weakening the vein walls. Thus, the rising prevalence of lymphatic and venous disorders is boosting the demand for home sequential compression device, thereby driving the market growth.

The Report Segments the Home Sequential Compression Devices Market as Follows:

By Device Type

Simultaneous Sequential Compression Device (SSCD))
Alternate Sequential Compression Device (ASCD)
By Type

Standard
Portable

By Application

Deep Vein Thrombosis (DVT)
Lymphedema Management
Chronic Venous Insufficiency (CVI)
Others

By Geography

North America
US
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle East and Africa
UAE
Saudi Arabia
South Africa
Rest of Middle East and Africa
South and Central America
Brazil
Argentina
Rest of South and Central America

Purchase a Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00019265/?openpr-10225

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.